electroCore (NASDAQ:ECOR – Get Free Report) is projected to post its quarterly earnings results after the market closes on Wednesday, March 12th. Analysts expect electroCore to post earnings of ($0.34) per share and revenue of $7.06 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
electroCore Price Performance
NASDAQ ECOR opened at $14.10 on Monday. electroCore has a 12 month low of $5.32 and a 12 month high of $19.49. The company has a 50-day moving average of $16.36 and a 200-day moving average of $12.16. The company has a market cap of $93.85 million, a P/E ratio of -7.70 and a beta of 0.24.
Wall Street Analyst Weigh In
Separately, HC Wainwright boosted their price objective on electroCore from $22.00 to $25.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th.
About electroCore
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
See Also
- Five stocks we like better than electroCore
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Pros And Cons Of Monthly Dividend Stocks
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.